Unresectable hepatocellular carcinoma: new opportunities and prospects for therapy
Hepatocellular carcinoma (HCC) is the most common liver malignancy and ranks sixth for cancer prevalence and fourth place among the causes of cancer mortality. Despite the improvement of diagnostic techniques, the diagnosis of HCC is still determined in the late stages. The absence of screening prog...
Main Authors: | Dzhamal T Abdurakhmanov, Valerii V Breder, Larisa V Bolotina, Vladislav Iu Kosyrev, Bela M Medvedeva, Vladislav V Petkau |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2019-06-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/33496/pdf |
Similar Items
-
HEPATOCELLULAR CARCINOMA AS A SOCIAL AND MEDICAL PROBLEM IN THE RUSSIAN FEDERATION
by: V. V. BREDER, et al.
Published: (2016-12-01) -
PHARMACOLOGICAL THERAPY OF HEPATOCELLULAR CANCER PRACTICAL ISSUES AND SOLUTIONS
by: V. V. Breder, et al.
Published: (2017-11-01) -
Etiopathogenetic Factors of Hepatocellular Carcinoma, Overall Survival, and Their Evolution over Time—Czech Tertiary Center Overview
by: Petr Hříbek, et al.
Published: (2022-08-01) -
Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma
by: Tetsu Tomonari, et al.
Published: (2023-10-01) -
Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib
by: Yen-Yang Chen, et al.
Published: (2020-11-01)